These observations indicate that ETS1-expressing EWS tumor cells have the potential to exhibit TNS3-dependent changes in their cytoskeleton that are consistent with the promotion of cell movement, a critical aspect of the metastatic process. This evidence concerns the gene ETS1 and neoplasm.